The Effect of Acid Suppression Therapy on the Safety and Efficacy of Plecanatide: Analysis of Randomized Phase III Trials.

Moshiree, Baharak; Schoenfeld, Philip; Franklin, Howard; Rezaie, Ali

Moshiree, Baharak; Schoenfeld, Philip; Franklin, Howard; Rezaie, Ali.

Affiliation

Moshiree B; Division of Gastroenterology, Hepatology, and Nutrition, Atrium Health, Charlotte, North Carolina. Electronic address: Baha.moshiree@atriumhealth.org.
Schoenfeld P; John D. Dingell Veterans Affairs Medical Center, Detroit, Michigan.
Franklin H; Salix Pharmaceuticals Inc, Bridgewater, New Jersey.
Rezaie A; Cedars-Sinai Medical Center, Los Angeles, California.

Clin Ther ; 44(1): 98-110.e1, 2022 01.

Article in En | MEDLINE | ID: mdl-35086735

Subject(s)

Constipation; Gastrointestinal Agents; Natriuretic Peptides; Adult; Chronic Disease; Constipation/drug therapy; Defecation; Double-Blind Method; Gastrointestinal Agents/adverse effects; Humans; Irritable Bowel Syndrome/drug therapy; Natriuretic Peptides/adverse effects; Treatment Outcome

Key words

constipation; functional gastrointestinal diseases; irritable bowel syndrome; plecanatide

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Constipation / Natriuretic Peptides Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: Clin Ther Year: 2022 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google